BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 31447216)

  • 1. Statin-induced muscular side effects at rest and exercise - An anatomical mapping.
    Berent T; Berent R; Steiner S; Sinzinger H
    Atheroscler Suppl; 2019 Dec; 40():73-78. PubMed ID: 31447216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Statin associated myopathy in clinical practice. Results of DAMA study].
    Millán J; Pedro-Botet J; Climent E; Millán J; Rius J
    Clin Investig Arterioscler; 2017; 29(1):7-12. PubMed ID: 27717598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An insight into statin use and its association with muscular side effects in clinical practice.
    Farcas A; Bucsa C; Leucuta D; Mogosan C; Bojita M; Dumitrascu D
    Rom J Intern Med; 2015; 53(2):153-60. PubMed ID: 26402985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statins, myalgia, and rhabdomyolysis.
    Tournadre A
    Joint Bone Spine; 2020 Jan; 87(1):37-42. PubMed ID: 30735805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Managing statin-induced muscle toxicity in a lipid clinic.
    Blaier O; Lishner M; Elis A
    J Clin Pharm Ther; 2011 Jun; 36(3):336-41. PubMed ID: 21414023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statin Associated Muscular Adverse Effects.
    Kammoun R; Charfi O; Lakhoua G; Zaiem A; Daghfous R; Kastalli S; Aouinti I; Aidli SE
    Curr Drug Saf; 2024; 19(1):114-116. PubMed ID: 36847228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Necrotizing Autoimmune myopathy: A case report on statin induced rhabdomyolysis requiring immunosuppressive therapy.
    Kunwar S; Parekh JD; Chilukuri RS; Andukuri VA
    Drug Discov Ther; 2018; 12(5):315-317. PubMed ID: 30464165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statin-associated myopathy.
    Thompson PD; Clarkson P; Karas RH
    JAMA; 2003 Apr; 289(13):1681-90. PubMed ID: 12672737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin-induced myopathies.
    Tomaszewski M; Stępień KM; Tomaszewska J; Czuczwar SJ
    Pharmacol Rep; 2011; 63(4):859-66. PubMed ID: 22001973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severity of statin-induced adverse effects on muscle and associated conditions: data from the DAMA study.
    Pedro-Botet J; Millán Núñez-Cortés J; Chillarón JJ; Flores-Le Roux JA; Rius J
    Expert Opin Drug Saf; 2016 Dec; 15(12):1583-1587. PubMed ID: 27645494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The genetics of statin-induced myopathy.
    Ghatak A; Faheem O; Thompson PD
    Atherosclerosis; 2010 Jun; 210(2):337-43. PubMed ID: 20042189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exercise-induced myalgia may limit the cardiovascular benefits of statins.
    Opie LH
    Cardiovasc Drugs Ther; 2013 Dec; 27(6):569-72. PubMed ID: 23934075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The clinical and muscular pathological features of statin-induced myopathy].
    Meng L; Lu Y; Zhang W; Wang Z; Lyu H; Yuan Y
    Zhonghua Nei Ke Za Zhi; 2015 Aug; 54(8):716-20. PubMed ID: 26674629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of statin myopathy after statin withdrawal.
    Armour R; Zhou L
    J Clin Neuromuscul Dis; 2013 Mar; 14(3):103-9. PubMed ID: 23492461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Managing statin myopathy.
    Venero CV; Thompson PD
    Endocrinol Metab Clin North Am; 2009 Mar; 38(1):121-36. PubMed ID: 19217515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management.
    Stroes ES; Thompson PD; Corsini A; Vladutiu GD; Raal FJ; Ray KK; Roden M; Stein E; Tokgözoğlu L; Nordestgaard BG; Bruckert E; De Backer G; Krauss RM; Laufs U; Santos RD; Hegele RA; Hovingh GK; Leiter LA; Mach F; März W; Newman CB; Wiklund O; Jacobson TA; Catapano AL; Chapman MJ; Ginsberg HN;
    Eur Heart J; 2015 May; 36(17):1012-22. PubMed ID: 25694464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Managing the underestimated risk of statin-associated myopathy.
    Rallidis LS; Fountoulaki K; Anastasiou-Nana M
    Int J Cardiol; 2012 Sep; 159(3):169-76. PubMed ID: 21813193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statin-induced apoptosis and skeletal myopathy.
    Dirks AJ; Jones KM
    Am J Physiol Cell Physiol; 2006 Dec; 291(6):C1208-12. PubMed ID: 16885396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statin induced myopathy.
    Frank RE
    J Insur Med; 2009; 41(2):132-5. PubMed ID: 19845216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk identification and possible countermeasures for muscle adverse effects during statin therapy.
    Magni P; Macchi C; Morlotti B; Sirtori CR; Ruscica M
    Eur J Intern Med; 2015 Mar; 26(2):82-8. PubMed ID: 25640999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.